The present invention discloses a clear stable solution of active fragment of bFGF, decapeptide for treatment of vitiligo. The invention further discloses a process for preparation of the clear stable solution of active fragment of bFGF.
Disclosed is an oral controlled release macrolide pharmaceutical formulation. In a preferred embodiment, the formulation comprises a citrate salt of a preferred macrolide, clarithromycin. Also disclosed are methods for preparing, isolating and characterizing soluble and stable citrate salt of macrolides and use ther...
Disclosed herein is a synergistic pharmaceutical composition comprising synergistic effective amount of Nitazoxanide and Ofloxacin or pharmaceutically acceptable salts thereof with pharmaceutically acceptable inert excipients selected from diluents, binders, disintegrating agents, glidants or lubricants. Further, th...
The present invention pertains to pharmaceutical formulations. More specifically, it pertains to a novel formulation of Curcumin which is freely soluble in water and is proposed to have an enhanced bioavailability.
The present invention discloses a novel non staining topical formulation of turmeric or extract thereof such as curcumin/curcuminoids. The same has been achieved by use of a novel combination of hydrophilic excipients viz. a specific solubilizer (SS) viz. Polyoxyl hydrogenated castor oil and a specialized base solut...
The present invention relates to a composition comprising ezetimibe and atorvastatin calcium. In particular, the present invention provides an immediate release bilayer tablet comprising one layer of atorvastatin calcium and other layer of ezetimibe and method for the preparation thereof, wherein ezetimibe is disper...
Present invention relates to a pharmaceutical composition in the form of modified release tablet comprising of granules having Mirabegron, one or more water insoluble hydrophilic excipient and optionally antioxidant, wherein granules are free of polyethylene oxide; and extragranular portion having of polyethylene ox...